Plasma prolactin and postmenopausal breast cancer risk: a pooled analysis of four prospective cohort studies
Jacob K. Kresovich(Moffitt Cancer Center), Susan E. Hankinson(University of Massachusetts Amherst), Minouk J. Schoemaker(Institute of Cancer Research), Michaël Pollak(McGill University), A. Heather Eliassen(Brigham and Women's Hospital), Aaron D. Norman(Mayo Clinic in Arizona), Sabina Rinaldi(St. Elizabeth's Hospital), Roger L. Milne(The University of Melbourne), Shelley S. Tworoger(Oregon Health & Science University), Catherine Guranich(University of Massachusetts Amherst), Maegan E. Boutot(University of Massachusetts Amherst), Celine M. Vachon(Leiden University Medical Center), Serena C. Houghton(University of Massachusetts Amherst), Montserrat García‐Closas(Institute of Cancer Research), Micheal E. Jones(Institute of Cancer Research), Christopher G. Scott(Mayo Clinic in Florida), Bernard Rosner(Brigham and Women's Hospital), Mitch Dowsett(Royal Marsden Hospital), Jing Qian(University of Massachusetts Amherst), Anthony J Swerdlow(Breast Cancer Now), Peter Kraft
Cited by 4
Related Papers
REPRODUCIBILITY AND VALIDITY OF A SEMIQUANTITATIVE FOOD FREQUENCY QUESTIONNAIRE
|American Journal of Epidemiology|1985|4.3k
Lack of Effect of Long-Term Supplementation with Beta Carotene on the Incidence of Malignant Neoplasms and Cardiovascular Disease
|New England Journal of Medicine|1996|2.4k
Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study
|The Lancet Public Health|2020|2.3k
Vitamin E Consumption and the Risk of Coronary Disease in Women
|New England Journal of Medicine|1993|2.1k